share_log

UBS Maintains Neutral on CareMax, Lowers Price Target to $6.4

Benzinga ·  Apr 1 21:24

UBS analyst A.J. Rice maintains CareMax (NASDAQ:CMAX) with a Neutral and lowers the price target from $7 to $6.4.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment